August 16, 2021
August 16, 2021 –
Genentech, the manufacturer of Actemra® (tocilizumab), has announced a global shortage of the drug's intravenous (IV) form due to high demand
August 16, 2021
August 16, 2021 –
Pfizer has recalled an additional four lots of Chantix® (varenicline) after identifying a nitrosamine impurity, N-nitroso-varenicline, above the manufacturer’s established acceptable
August 16, 2021
August 16, 2021 –
The U.S. FDA has approved Merck’s WeliregTM (belzutifan), the first hypoxia-inducible
factor-2 alpha (HIF-2α) inhibitor to become
August 13, 2021
August 13, 2021 –
The U.S. FDA has expanded approval for Mirena® (levonorgestrel-releasing intrauterine
system), an intrauterine device (IUD) manufactured by Bayer, to prevent pregnancy
August 13, 2021
August 13, 2021 –
TicoVacTM (tick-borne encephalitis vaccine), manufactured by Pfizer, has received FDA approval to provide active immunization to prevent
August 12, 2021
August 12, 2021 –
The U.S. FDA has approved a new indication for Xywav® (calcium/magnesium/
potassium/sodium oxybates) oral solution
August 12, 2021
August 12, 2021 –
Cipla has received final approval from the U.S. FDA for its generic version of Durezol®
(difluprednate ophthalmic emulsion – Novartis) 0.5%.
August 12, 2021
August 12, 2021 –
The U.S. FDA has modified the emergency use authorization (EUA) for both the Pfizer